This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Annual Review of Immunology | |
|---|---|
| Title | Annual Review of Immunology |
| Discipline | Immunology |
| Abbreviation | Annu. Rev. Immunol. |
| Publisher | Annual Reviews |
| Country | United States |
| Frequency | Annually |
| History | 1983–present |
| Impact | (varies yearly) |
Annual Review of Immunology is a peer-reviewed annual journal that publishes comprehensive review articles in the field of immunology. Founded in the early 1980s, it synthesizes advances across immunology, vaccinology, cellular biology, molecular biology, structural biology, and clinical research from contributors affiliated with institutions such as Harvard University, Stanford University, Massachusetts Institute of Technology, Johns Hopkins University, and University of Oxford. The journal serves researchers, clinicians, and policy-makers connected to organizations including Centers for Disease Control and Prevention, World Health Organization, National Institutes of Health, Howard Hughes Medical Institute, and Wellcome Trust.
The journal was established amid concurrent developments at institutions like Cold Spring Harbor Laboratory, Salk Institute, Rockefeller University, and Pasteur Institute following landmark discoveries by scientists associated with Nobel Prize winners such as Baruj Benacerraf, Jean Dausset, Georges Köhler, Niels K. Jerne, and Susumu Tonegawa. Early editorial leadership drew on figures connected to Royal Society, National Academy of Sciences, American Association for the Advancement of Science, and Royal Institution, reflecting influences from conferences like the Keystone Symposia on Molecular and Cellular Biology and meetings at Gordon Research Conferences. Over decades the journal has paralleled breakthroughs at laboratories affiliated with Addenbrooke's Hospital, Mayo Clinic, Cleveland Clinic, Institut Pasteur de Lille, and Max Planck Society centers, and tracked paradigm shifts attributed to research programs funded by entities like European Research Council and Medical Research Council. Editorial transitions mirrored wider trends seen at publications from Nature Publishing Group, Cell Press, and Science/AAAS.
The journal covers topics spanning innate immunity and adaptive immunity, with contributions connected to work from groups at Fred Hutchinson Cancer Research Center, Dana-Farber Cancer Institute, Karolinska Institutet, and Tokyo University. Reviews synthesize data from laboratories employing technologies pioneered at EMBL, Lawrence Berkeley National Laboratory, Argonne National Laboratory, and projects linked to initiatives like Human Genome Project and Human Cell Atlas. Subject matter includes antigen presentation research from teams at University of California, San Francisco, cytokine biology mapped by groups at University of Pennsylvania, immunogenetics informed by studies at Broad Institute, and translational immunotherapy developments at Memorial Sloan Kettering Cancer Center. Articles also contextualize findings with respect to public health responses led by Centers for Medicare & Medicaid Services, vaccine deployment strategies by Gavi, the Vaccine Alliance, and pandemic science discussed among stakeholders including Coalition for Epidemic Preparedness Innovations.
Editorial practices reflect norms established by professional bodies such as Committee on Publication Ethics, International Committee of Medical Journal Editors, and governance models used by publishing houses like Wiley-Blackwell and Oxford University Press. The editorial board traditionally comprises scholars affiliated with Princeton University, Yale University, University of Chicago, Columbia University, University of California, San Diego, and international partners at University of Toronto, University of Melbourne, ETH Zurich, and University of Cambridge. Peer-review standards align with criteria emphasized by National Library of Medicine indexing and follow conflict-of-interest policies similar to those at American Medical Association journals. Commissioning and planning draw on networks involving program officers from National Institute of Allergy and Infectious Diseases, funding bodies like Bill & Melinda Gates Foundation, and advisory input from consortia such as European Molecular Biology Organization.
The journal is indexed in major databases and platforms operated by Clarivate Analytics and Elsevier; citation metrics are tracked by tools produced by Institute for Scientific Information, Scopus, and Google Scholar. Its impact is often compared with leading reviews published by Nature Reviews Immunology, Trends in Immunology, Immunity, Cell, and Science Translational Medicine. Institutional subscriptions span libraries at Library of Congress, British Library, Bibliothèque nationale de France, and university systems across State University of New York and University of California campuses. Citation analyses frequently reference authors based at Scripps Research, Ragon Institute, Weizmann Institute of Science, and McGill University.
Seminal reviews have synthesized work on T cell receptor rearrangement pioneered by groups connected to Cold Spring Harbor Laboratory and Salk Institute, B cell biology studied at Weill Cornell Medicine and Imperial College London, and dendritic cell function reported by researchers at Karolinska Institutet and University College London. Influential contributions have linked structural immunology advances from European Synchrotron Radiation Facility and Diamond Light Source to vaccine design efforts at Institut Pasteur and computational immunology from labs at University of Washington and University of California, Santa Barbara. Reviews have illuminated mechanisms relevant to clinical trials at National Institutes of Health Clinical Center, outcomes reported by investigators at Rheumatology Research Foundation and American Cancer Society, and policy implications debated within World Health Assembly forums.
Published annually by Annual Reviews, the journal offers print volumes housed in collections at repositories like Bodleian Libraries and digital access through institutional platforms used by subscribers including universities, hospitals, and research institutes such as Johns Hopkins University School of Medicine, Imperial College Healthcare NHS Trust, and Karolinska University Hospital. Formats include hardcover, paperback, PDF chapters, and metadata disseminated to aggregators operated by EBSCO, ProQuest, and JSTOR. Rights and licensing practices engage stakeholders represented by Creative Commons conversations and library consortia such as SCOAP3 and HathiTrust.
Category:Immunology journals